HLA-C*06 and response to ustekinumab in Caucasian patients with psoriasis: Outcome and long-term follow-up

J Am Acad Dermatol. 2016 Feb;74(2):374-5. doi: 10.1016/j.jaad.2015.08.055.

Authors

Marina Talamonti¹, Marco Galluzzo², Sergio Chimenti², Antonio Costanzo³

Affiliations

¹ Department of Dermatology, University of Rome "Tor Vergata", Rome, Italy. Electronic address: [email protected].
² Department of Dermatology, University of Rome "Tor Vergata", Rome, Italy.
³ Dermatology Unit, Neurosciences, Mental Health, and Sensory Organs Department, Sapienza University of Rome, Rome, Italy.

PMID: 26775778
DOI: 10.1016/j.jaad.2015.08.055

No abstract available

Publication types

Letter

MeSH terms

Adult
Aged
Alleles
Biomarkers
Dermatologic Agents / therapeutic use*
Female
Genotype
HLA-C Antigens / genetics*
Humans
Male
Middle Aged
Psoriasis / drug therapy*
Psoriasis / genetics*
Retrospective Studies
Severity of Illness Index
Ustekinumab / therapeutic use*
White People*
Young Adult

Substances

Biomarkers
Dermatologic Agents
HLA-C Antigens
HLA-C*06 antigen
Ustekinumab